Aside from the MFN order, President Trump is also in the process of negotiating tariffs with countries all over the world. It ...

Bristol-Myers Squibb remains a compelling Buy despite the market's over-reaction to the industry and macro headwinds. Learn ...

Regions face reduced federal research funding and shrinking venture capital for startups, though rankings stay consistent.

The CDC has informed public health experts and physician organizations, whose views are considered in shaping the U.S. vaccine policy, that their services are no longer required for a key vaccine ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Pfizer PFE will report its second-quarter 2025 earnings on Aug. 5, before market open. The Zacks Consensus Estimate for sales ...

Pfizer (PFE) and BioNTech (BNTX) lose bid to appeal a High Court ruling that issued Moderna (MRNA) a COVID-19 vaccine patent ...

CAMBRIDGE, MA / ACCESS Newswire / August 1, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the UK Court of Appeal ...

Brokerage Investec downgraded Sun Pharma shares by two notches to 'sell' while Choice Equity Broking gave an 'Add' rating ...

Bristol Myers Squibb (BMY) stock nosedived 4.2% today after a disappointing earnings forecast cut. The bio-pharma giant's ...